Found: 16
Select item for more details and to access through your institution.
Prévenir la progression de la pathologie Tau par immunothérapie passive.
- Published in:
- Médecine Sciences, 2015, v. 31, n. 2, p. 132, doi. 10.1051/medsci/20153102006
- By:
- Publication type:
- Article
Ouvrir le cerveau à de nouvelles thérapies.
- Published in:
- Médecine Sciences, 2014, v. 30, n. 5, p. 486, doi. 10.1051/medsci/20143005004
- By:
- Publication type:
- Article
Reduction of phosphorylated tau aggregates in TauPS2APP transgenic mice by passive immunotherapy with an anti-tau/pS422 antibody
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy.
- Published in:
- Acta Neuropathologica Communications, 2016, v. 4, p. 1, doi. 10.1186/s40478-016-0292-9
- By:
- Publication type:
- Article
Trafficking of Endogenous Immunoglobulins by Endothelial Cells at the Blood-Brain Barrier.
- Published in:
- Scientific Reports, 2016, p. 25658, doi. 10.1038/srep25658
- By:
- Publication type:
- Article
A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43606-3
- By:
- Publication type:
- Article
Region-specific permeability of the blood–brain barrier upon pericyte loss.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2017, v. 37, n. 12, p. 3683, doi. 10.1177/0271678X17697340
- By:
- Publication type:
- Article
Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)‐[<sup>11</sup>C]YH132: Application in Drug Development and Neurodegenerative Diseases.
- Published in:
- ChemBioChem, 2024, v. 25, n. 7, p. 1, doi. 10.1002/cbic.202300819
- By:
- Publication type:
- Article
Intracellular transport and regulation of transcytosis across the blood-brain barrier.
- Published in:
- Cellular & Molecular Life Sciences, 2019, v. 76, n. 6, p. 1081, doi. 10.1007/s00018-018-2982-x
- By:
- Publication type:
- Article
Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease.
- Published in:
- Brain: A Journal of Neurology, 2014, v. 137, n. 10, p. 2834, doi. 10.1093/brain/awu213
- By:
- Publication type:
- Article
APC nuclear membrane association and microtubule polarity.
- Published in:
- Biology of the Cell (Wiley-Blackwell), 2008, v. 100, n. 4, p. 243, doi. 10.1042/BC20070123
- By:
- Publication type:
- Article
A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature.
- Published in:
- PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0268590
- By:
- Publication type:
- Article
Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche's Endocannabinoid System Projects.
- Published in:
- Chimia, 2024, v. 78, n. 7/8, p. 499, doi. 10.2533/chimia.2024.499
- By:
- Publication type:
- Article
muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-19894-4
- By:
- Publication type:
- Article
Fenebrutinib, a Bruton's tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways.
- Published in:
- Journal of Neuroinflammation, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12974-024-03267-5
- By:
- Publication type:
- Article